VANESSA CORDOVA: Open Payments
NPI 1740735745 · VISTA, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,814 in 113 payments from 28 companies in 2025. Trend: 2023 $2,640 · 2024 $2,002 · 2025 $2,814
Food & beverage: $2,812Travel & lodging: $2
| Company | Payments | Amount |
|---|---|---|
| Lilly USA, LLC | 12 | $609 |
| AstraZeneca Pharmaceuticals LP | 14 | $277 |
| Intra-Sana Laboratories | 11 | $275 |
| ABBVIE INC. | 11 | $240 |
| Bayer Healthcare Pharmaceuticals Inc. | 12 | $197 |
| Novo Nordisk Inc | 8 | $181 |
| GlaxoSmithKline, LLC. | 8 | $140 |
| Lundbeck LLC | 3 | $81 |
| Amgen Inc. | 3 | $62 |
| Edwards Lifesciences Corporation | 2 | $60 |
Products named: KISUNLA, AIRSUPRA, ZEPBOUND, RELTONE 200 MG, REXULTI, GLYCATE, QULIPTA, TRELEGY ELLIPTA.
Industry payments across CA — which companies pay providers there.
